EcoDrugPlus

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSCHAG00000021058
Gene Symbol: AVPR1A
3 Cross references
189 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSCHAG00000020900
Gene Symbol: AVPR1AB
1 Cross references
135 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSCHAG00000025705
Gene Symbol: AVPR2
1 Cross references
197 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSCHAG00000012945
Gene Symbol: AVPR2
1 Cross references
197 Possible Orthologues:

Aromatase-Like

Ensembl ID : ENSCHAG00000027387
Gene Symbol: LOC105889015
3 Cross references
255 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSCHAG00000009943
Gene Symbol: AURKA
1 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSCHAG00000008856
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSCHAG00000021398
Gene Symbol: BACE1
1 Cross references
221 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCHAG00000004155
Gene Symbol: BDKRB2
3 Cross references
286 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSCHAG00000004545
Gene Symbol: BDKRB2
3 Cross references
159 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSCHAG00000010524
Gene Symbol: CACNA1C
1 Cross references
215 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSCHAG00000017741
Gene Symbol: CACNA1DA
1 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).